GlaxoSmithKline Pharmaceuticals Ltd

NSE: GLAXO · BSE: 500660 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹2,628.40
Market cap: ₹44,527 Cr
Revenue (annual): ₹3,822 Cr
Net profit (annual): ₹1,036 Cr
P/E (TTM): 41.7×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 4.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Management Change 5 Annual General Meeting 5 Other Announcement 4 Financial Results 3 Results Update 2 Legal & Regulatory 2 Board Meeting Outcome 2 Price Movement Clarification 1 Dividend 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Jul 2026 11:59 IST BSE

Board Meeting Date

GlaxoSmithKline Pharmaceuticals Board Meeting Date

GlaxoSmithKline Pharmaceuticals Ltd scheduled a board meeting for August 3, 2026. The board will consider and approve un-audited financial results for Q1 ended June 30, 2026.

Read the filing ↗